This compound is a pharmaceutical intermediate featuring a benzoic acid moiety linked to an isoxazole ring and a pentoxyphenyl substituent. It is primarily utilized in research and manufacturing settings as a building block for active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 179162-55-1
4-Bromo-2-fluorobenzoic acid methyl ester
pharmaceutical intermediate
3-aminoazepan-2-one
pharmaceutical intermediate
Amikacin Impurity 11
pharmaceutical intermediate
(S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydroxycyclohexyl)-2-hydroxybutanamide
pharmaceutical intermediate
4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoic acid
PDTXSIGPZDVVIX-UHFFFAOYSA-N
CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)O